comparemela.com

Latest Breaking News On - Vr target vessel revascularization - Page 1 : comparemela.com

Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI

Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.

United kingdomNew yorkUnited statesGloriam steiner gagerShao liang chenJolantam siller matulaWayne batchelorIcahn school of medicineVascular instituteAcademic research consortiumUniversity of viennaMount sinai health systemDuke universityAmerican college of cardiology scientific sessionInternational society on thrombosisNew york city

Post-PCI FFR in Multivessel Disease Predicts Target Vessel Failure

In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.

United statesZsolt pirothGottsegen institute of cardiologyBrown universityBoston scientificGottsegen instituteNew england journalTranscatheter cardiovascular therapeuticsCardiovascular interventionsAbbott vascularMyocardial infarctionCoronary artery bypass graftPercutaneous coronary interventionImplanted device cardiology Target vessel revascularizationVr target vessel revascularization

QFR-Guided PCI Benefits Build Over Time: FAVOR III China

The sham-controlled study found clinical outcomes improved incrementally over time, compared with PCI guided by angiographic assessment of lesions.

United statesAzienda ospedaliero universitaria policlinicoColl cardiolErica cohenDaiichi sankyo eli lillyGarys mintzDavide capodannoVittorio emanueleUnion medical collegeNational centerNational clinical research centerBoston scientificJournal of the american college cardiologySunnybrook health sciences centreChinese academy of medical sciencesTechnology commission

vimarsana © 2020. All Rights Reserved.